Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Postmortem calpain changes in ostrich skeletal muscle.

Chang YS, Hsu DH, Stromer MH, Chou RG.

Meat Sci. 2016 Jul;117:117-21. doi: 10.1016/j.meatsci.2016.03.004. Epub 2016 Mar 5.

PMID:
26971307
2.

Determinants of the differential antizyme-binding affinity of ornithine decarboxylase.

Liu YC, Hsu DH, Huang CL, Liu YL, Liu GY, Hung HC.

PLoS One. 2011;6(11):e26835. doi: 10.1371/journal.pone.0026835. Epub 2011 Nov 3.

3.

erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+ in immunohistochemical analysis.

Lan C, Liu JM, Liu TW, Hsu DH, Liang S, Chen JR, Peng JW.

Am J Clin Pathol. 2005 Jul;124(1):97-102.

PMID:
15923160
4.

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer.

Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, Hsu DH, Le Pecq JB, Lyerly HK.

J Transl Med. 2005 Feb 21;3(1):9.

5.

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.

André F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu DH, Tursz T, Amigorena S, Angevin E, Zitvogel L.

J Immunol. 2004 Feb 15;172(4):2126-36.

6.

Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides.

Hsu DH, Paz P, Villaflor G, Rivas A, Mehta-Damani A, Angevin E, Zitvogel L, Le Pecq JB.

J Immunother. 2003 Sep-Oct;26(5):440-50.

PMID:
12973033
7.

Production and characterization of clinical grade exosomes derived from dendritic cells.

Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, Ruegg C, Le Pecq JB.

J Immunol Methods. 2002 Dec 15;270(2):211-26.

PMID:
12379326
8.

HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro.

Cole MS, Stellrecht KE, Shi JD, Homola M, Hsu DH, Anasetti C, Vasquez M, Tso JY.

Transplantation. 1999 Aug 27;68(4):563-71.

PMID:
10480417
9.

A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees.

Hsu DH, Shi JD, Homola M, Rowell TJ, Moran J, Levitt D, Druilhet B, Chinn J, Bullock C, Klingbeil C.

Transplantation. 1999 Aug 27;68(4):545-54.

PMID:
10480415
10.

Pharmacology and safety assessment of humanized monoclonal antibodies for therapeutic use.

Klingbeil C, Hsu DH.

Toxicol Pathol. 1999 Jan-Feb;27(1):1-3. Review.

PMID:
10367664
11.

A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.

Eastman S, Deftos M, DeRoos PC, Hsu DH, Teyton L, Braunstein NS, Hackett CJ, Rudensky A.

Eur J Immunol. 1996 Feb;26(2):385-93.

PMID:
8617308
12.

A unique pattern of lymphokine synthesis is a characteristic of certain antigen-specific suppressor T cell clones.

Nanda NK, Sercarz EE, Hsu DH, Kronenberg M.

Int Immunol. 1994 May;6(5):731-7.

PMID:
7802868
13.

A receptor for interleukin 10 is related to interferon receptors.

Ho AS, Liu Y, Khan TA, Hsu DH, Bazan JF, Moore KW.

Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11267-71.

14.

Dyspnea in dying patients.

Hsu DH.

Can Fam Physician. 1993 Jul;39:1635-8. Review.

15.
16.

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Rousset F, Garcia E, Defrance T, Péronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J.

Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890-3.

17.

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

Hsu DH, de Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, de Vries J, Spits H, Mosmann TR, Moore KW.

Science. 1990 Nov 9;250(4982):830-2.

PMID:
2173142
18.

Structure and expression of cloned Fc gamma receptors.

Moore KW, Hsu DH.

Res Immunol. 1990 Jan;141(1):68-74; discussion 105-8. Review. No abstract available.

PMID:
1693216
19.
20.
21.

Circular fringe carrier technique in holographic interferometry.

Long P, Hsu DH, Wang B.

Appl Opt. 1987 Oct 1;26(19):4282-4. doi: 10.1364/AO.26.004282.

PMID:
20490222
22.

Implementation of health hazard appraisal and its impediments.

Hsu DH, Milsum JH.

Can J Public Health. 1978 May-Jun;69(3):227-32. No abstract available.

PMID:
667772

Supplemental Content

Support Center